Early Administration of Anti–SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early Administration of Anti–SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients
Authors
Keywords
-
Journal
Kidney International Reports
Volume 7, Issue 6, Pages 1241-1247
Publisher
Elsevier BV
Online
2022-03-27
DOI
10.1016/j.ekir.2022.03.020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19
- (2021) Robert L. Gottlieb et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The antigenic anatomy of SARS-CoV-2 receptor binding domain
- (2021) Wanwisa Dejnirattisai et al. CELL
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
- (2021) Noa Dagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
- (2021) Robert Challen et al. BMJ-British Medical Journal
- Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
- (2021) Brian J. Boyarsky et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Casirivimab-Imdevimab for Treatment of COVID-19 in Solid Organ Transplant Recipients
- (2021) Abhay Dhand et al. TRANSPLANTATION
- Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
- (2021) Nathalie Chavarot et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Efficiency of a boost with a third dose of anti‐SARS‐CoV‐2 messenger RNA‐based vaccines in solid organ transplant recipients
- (2021) Arnaud Del Bello et al. AMERICAN JOURNAL OF TRANSPLANTATION
- SnapShot: SARS-CoV-2 antibodies
- (2021) David C. Montefiori et al. Cell Host & Microbe
- Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019
- (2021) Ravindra Ganesh et al. JOURNAL OF INFECTIOUS DISEASES
- Occurrence of severe COVID-19 in vaccinated transplant patients
- (2021) Sophie Caillard et al. KIDNEY INTERNATIONAL
- Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients
- (2021) Ilies Benotmane et al. KIDNEY INTERNATIONAL
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
- (2021) Nassim Kamar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
- (2021) Meagan P. O’Brien et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
- (2021) Victoria G. Hall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bamlanivimab use in mild‐to‐moderate COVID‐19 disease: A matched cohort design
- (2021) Christopher J. Destache et al. PHARMACOTHERAPY
- Broad betacoronavirus neutralization by a stem helix–specific human antibody
- (2021) Dora Pinto et al. SCIENCE
- Anti-SARS-Cov-2 Monoclonal Antibodies in Solid-Organ-Transplant Patients
- (2021) Arnaud Del Bello et al. TRANSPLANTATION
- Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail
- (2021) Arnaud C. Drouin et al. Viruses-Basel
- SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
- (2021) Markus Hoffmann et al. Cell Reports
- Real-world Effectiveness and Tolerability of Monoclonal Antibody Therapy for Ambulatory Patients With Early COVID-19
- (2021) Brandon J Webb et al. Open Forum Infectious Diseases
- Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
- (2021) Anil Gupta et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Responses after a Third Dose of COVID-19 Vaccine in Kidney Transplant Recipients and Patients Treated for Chronic Lymphocytic Leukemia
- (2021) Julien Marlet et al. Vaccines
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
- (2020) Dora Pinto et al. NATURE
- An initial report from the French SOT COVID Registry suggests high mortality due to Covid-19 in recipients of kidney transplants.
- (2020) Sophie Caillard et al. KIDNEY INTERNATIONAL
- COVID‐19 severity in kidney transplant recipients is similar to nontransplant patients with similar comorbidities
- (2020) Nathalie Chavarot et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Is Covid‐19 infection more severe in kidney transplant recipients?
- (2020) Sophie Caillard et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
- (2020) David M. Weinreich et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
- (2020) Peter Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More